We currently intend to focus on opportunities to acquire U.S. companies operating in the technology industry. (Incorporated in Delaware)  Cloud platform services, supply chain technologies, e-sports and companies serving hybrid work forces are among the businesses that we will consider for a business combination. Our management team is led by Arie Rabinowitz, our CEO and […]

(Apollo-backed SPAC Spartan Acquisition Corp. IV withdrew its SPAC IPO plans in an SEC filing dated June 29, 2022; this SPAC’s confidential IPO filing was made on March 3, 2021, and its S-1 was filed March 24, 2021.) We intend to focus our search on a target business in the energy value chain in North […]

Erayak Power Solution Group Inc. was formed in 2019 under the laws of the Cayman Islands. We conduct business primarily through our wholly owned subsidiaries, Zhejiang Leiya and Wenzhou New Focus, in the People’s Republic of China, or the PRC. Our company specializes in the manufacturing, research and development (“R&D”), and wholesale and retail of […]

We are a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO, our lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. THIO will enter Phase 2 human trials (THIO-101) in Australia and Europe in the first half of 2022. Patients with advanced Non-Small Cell Lung Cancer (NSCLC) […]

We are a provider of integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. (Incorporated in the Cayman Islands) We use a fabless business model. We specialize in the front end and back end of IC design, which are the major components of the IC product development chain. We have established strong supply […]

(Note: Clearmind Medicine, Inc. priced its NASDAQ uplisting – a public offering of 1.15 million shares (1,153,847 shares) at $6.50 per share – on Nov. 14, 2022, to raise $7.48 million. The pricing terms represented fewer shares than in the prospectus – 1.15 million shares price, down from 1.26 million shares in the SEC filing […]

(Note: Switchback III Corp. withdrew its IPO plans in an SEC filing dated June 29, 2022. The SPAC, also known as a blank check company, filed its S-1 on Feb. 26, 2021. The company had planned to offer 27.5 million units at $10.00 each to raise $275 million. Each unit was to consist of common stock […]

(Note: This is a unit IPO of a Tel Aviv-based company. Each unit consists of one share of common stock and one warrant to buy one share of common stock. IPOScoop has NO CALL on unit IPOs (unless they are SPACs or blank check companies).) We are an e-commerce consumer products goods (CPG) company operating primarily […]

Genelux is a clinical-stage biopharmaceutical company focused on developing a pipeline of next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Our most advanced product candidate, Olvi-Vec (olvimulogene nanivacirepvec), is a proprietary modified strain of the vaccinia virus (VACV), a stable DNA virus with a large engineering capacity. We have met the preestablished endpoint […]

(Note: Advaxis, Inc. withdrew its plan for a NASDAQ uplisting – a unit offering of stock and warrants – in an SEC filing dated June 27, 2022. The company did not intend to list the warrants on the NASDAQ. Advaxis filed an S-1 on May 12, 2022, for the public offering in connection with the […]